In silico identification of novel lncRNAs with a potential role in diagnosis of gastric cancer

Encieh Delshad,Fatemeh T. Shamsabadi,Shabbou Bahramian,Fatemeh Mehravar,Hossein Maghsoudi,Mohammad Shafiee

DOI: https://doi.org/10.1080/07391102.2019.1624615

2019-06-08

Journal of Biomolecular Structure and Dynamics

Abstract:Gastric cancer (GC) is the second leading cause of cancer-related deaths in the world. Due to the shortage of adequate symptoms in the early stages, it is diagnosed when the tumor has spread to distant organs. Early recognition of GC enhances the chance of successful treatment. Molecular mechanisms of GC are still poorly understood. LncRNAs are emerging as new players in cancer in both oncogene and tumor suppressor roles. High-throughput technologies such as RNA-Seq, have revealed thousands of lncRNAs which are dysregulated in GC. In this study, we retrieved lncRNAs obtained by High-throughput technologies from OncoLnc database. Consequently, retrieved lncRNAs were compared in literature-based databases including PubMed. As a result, two lists, including experimentally validated lncRNAs and predicted lncRNAs were provided. We found 43 predicted lncRNAs that had not been experimentally validated in GC, so far. Further Bioinformatics analyses were performed to obtain the expression profile of predicted lncRNAs in tumor and normal tissues. Also, the roles and targets of predicted lncRNAs in GC were identified by related databases. Finally, using the GEPIA database was reviewed the significant relationship of predicted lncRNAs with the survival of GC patients. By recognizing the lncRNAs involved in initiation and progression of GC, they may be considered as potential biomarkers in the GC early diagnosis or targeted treatment and lead to novel therapeutic strategies.Communicated by Ramaswamy H. Sarma

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to identify new long non - coding RNAs (lncRNAs) with potential roles in the diagnosis of gastric cancer (GC) by in silico computer simulation methods. Gastric cancer is the second leading cause of cancer - related deaths worldwide. Due to the lack of obvious early symptoms, it is usually diagnosed when the tumor has already spread to distant organs. Therefore, early identification of gastric cancer can significantly increase the chances of successful treatment. However, the molecular mechanisms of gastric cancer are still poorly understood. Long non - coding RNAs (lncRNAs), as new cancer participants, are gradually showing their importance in the roles of oncogenes and tumor suppressor genes. High - throughput technologies (such as RNA - Seq) have revealed thousands of lncRNAs that are abnormally expressed in gastric cancer.

In this study, the authors obtained lncRNAs obtained by high - throughput technologies from the OncoLnc database and compared them with lncRNAs in literature - based databases (such as PubMed), and finally provided two lists, including experimentally verified lncRNAs and predicted lncRNAs. The study found that 43 predicted lncRNAs have not been experimentally verified in gastric cancer. Further bioinformatics analysis was used to obtain the expression profiles of these predicted lncRNAs in tumor and normal tissues, and at the same time, the roles and targets of these predicted lncRNAs in gastric cancer were determined through relevant databases. Finally, the GEPIA database was used to examine the significant relationships between these predicted lncRNAs and the survival rates of gastric cancer patients.

By identifying lncRNAs involved in the occurrence and development of gastric cancer, they may serve as potential biomarkers for early diagnosis or targeted treatment of gastric cancer, thus leading to new treatment strategies. This will not only help in the early diagnosis of gastric cancer but also provide new directions for the development of more effective targeted anti - cancer drugs.